Bionoxx Inc.
PrivateLast Round
Series B
Mar 21, 2023
Total Funding Raised
$17.26M
Company Overview
Bionoxx Inc. is a biotechnology company that develops neutrophil-directed T cell modulation technology to fight cancer and immune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionoxx Inc. Comparables
Compare Bionoxx Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SillaJen Inc | 81% | |
| VacV Biotherapeutics | 80% | |
| KaliVir Immunotherapeutics | 80% |
Bionoxx Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 21, 2023 | ||||
| Series B | Apr 1, 2019 |
Bionoxx Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series B |
| ROI Investment Partners | Series B |
| Yuanta Investment | Series B |
| ID Ventures | Series B |
| Daekyo Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 27, 2024
Grew 36% QoQ, from 11 to 15 employees.
- Oct 20, 2024
Grew 27% QoQ, from 11 to 14 employees.
Bionoxx Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bionoxx Inc.'s valuation, stock price, and market status.
Is Bionoxx Inc. a public or private company?
Bionoxx Inc. is a private company.
What is the current stock price of Bionoxx Inc.?
Bionoxx Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Bionoxx Inc. worth (valuation)?
Valuation information for Bionoxx Inc. is not publicly available.
Can I buy Bionoxx Inc. stock?
Bionoxx Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bionoxx Inc.'s last funding round?
Bionoxx Inc.'s most recent funding round was Series B on March 21, 2023.
Who are the main investors in Bionoxx Inc.?
Key investors in Bionoxx Inc. include Yuanta Investment, Daekyo Investment.
Will Bionoxx Inc. IPO soon?
No public IPO plans have been announced for Bionoxx Inc..
How can I track Bionoxx Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bionoxx Inc.'s secondary market activity and sign up for updates.